Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cancer vaccines market reached a value of US$ 5.43 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 10.72 Billion by 2027, exhibiting a CAGR of 11.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. 

Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated through the use of various medications and vaccines. Between these, vaccines are broadly categorized into preventive and therapeutic. Preventive cancer vaccines are deployed for eliminating cancer caused by oncovirus and protecting from human papillomavirus (HPV), whereas therapeutic vaccines aid in stimulating the individual adaptive immune systems by using tumor antigens. At present, cancer vaccines are commercially available in varying types, such as antigen, dendritic cell, and anti-idiotype. 

Cancer Vaccines Market Trends:

The increasing prevalence of cancer, especially due to the rising consumption of tobacco-based products and evolving lifestyles is currently driving the cancer vaccines market growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel cancer vaccines, along with extensive fundings in the field of viral recombinant cancer vaccines are further facilitating the widespread adoption of these vaccines in the healthcare sector. In line with this, the extensive utilization of United States Food and Drug Administration (US FDA) approved vaccines, including human papillomavirus vaccine (HPV) and hepatitis B vaccine (HBV) to reduce the risk of certain types of cancer, such as liver cancer, is contributing to the market growth. The market is also significantly driven by rapid technological advancements focusing on the development of effective and specific cancer treatments. Other factors, such as improving healthcare infrastructure, rising geriatric population, who are susceptible to various chronic ailments, including cancer, and growing consumer awareness regarding the symptoms and the available treatment options, are creating a positive outlook for the market further across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer vaccines market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, technology, indication and end user.

Breakup by Type:

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines
     

Breakup by Technology:

  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines
  • Viral Vector and DNA Cancer Vaccines
  • Whole-cell Cancer Vaccines
     

Breakup by Indication:

  • Cervical Cancer
  • Prostate Cancer
  • Others
     

Breakup by End User:

  • Pediatrics
  • Adults
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Technology, Indication, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global cancer vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cancer vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cancer vaccines market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Cancer Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Preventive Cancer Vaccines
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Therapeutic Cancer Vaccines
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Technology
    7.1    Dendritic Cells Cancer Vaccines
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Recombinant Cancer Vaccines
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Antigen/Adjuvant Cancer Vaccines
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Viral Vector and DNA Cancer Vaccines
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Whole-cell Cancer Vaccines
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Indication
    8.1    Cervical Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Prostate Cancer
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by End User
    9.1    Pediatrics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Adults
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Anixa Biosciences Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Dendreon Pharmaceuticals LLC
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Dynavax Technologies Corporation
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
        15.3.4    GSK plc
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Merck & Co. Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Moderna Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
        15.3.7    OSE Immunotherapeutics
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
        15.3.8    Providence Therapeutics
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Sanofi S.A.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    UbiVac Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    Vaccitech plc
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials

List of Figures

Figure 1: Global: Cancer Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Cancer Vaccines Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cancer Vaccines Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cancer Vaccines Market: Breakup by Type (in %), 2021
Figure 5: Global: Cancer Vaccines Market: Breakup by Technology (in %), 2021
Figure 6: Global: Cancer Vaccines Market: Breakup by Indication (in %), 2021
Figure 7: Global: Cancer Vaccines Market: Breakup by End User (in %), 2021
Figure 8: Global: Cancer Vaccines Market: Breakup by Region (in %), 2021
Figure 9: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Cancer Vaccines (Cervical Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Cancer Vaccines (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Cancer Vaccines (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Cancer Vaccines (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Cancer Vaccines (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Cancer Vaccines (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Cancer Vaccines (Pediatrics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Cancer Vaccines (Pediatrics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Cancer Vaccines (Adults) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Cancer Vaccines (Adults) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: North America: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: North America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: United States: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: United States: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Canada: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Canada: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Asia-Pacific: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Asia-Pacific: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: China: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: China: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Japan: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Japan: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: India: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: India: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: South Korea: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: South Korea: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Australia: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Australia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Indonesia: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Indonesia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Europe: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Europe: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Germany: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Germany: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: France: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: France: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: United Kingdom: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: United Kingdom: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Italy: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Italy: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Spain: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Spain: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Russia: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Russia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Latin America: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Latin America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Brazil: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Brazil: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Mexico: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Mexico: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Middle East and Africa: Cancer Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Middle East and Africa: Cancer Vaccines Market: Breakup by Country (in %), 2021
Figure 81: Middle East and Africa: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Global: Cancer Vaccines Industry: SWOT Analysis
Figure 83: Global: Cancer Vaccines Industry: Value Chain Analysis
Figure 84: Global: Cancer Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Vaccines Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cancer Vaccines Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Cancer Vaccines Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Cancer Vaccines Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 5: Global: Cancer Vaccines Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Cancer Vaccines Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Cancer Vaccines Market: Competitive Structure
Table 8: Global: Cancer Vaccines Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4